SUBSCRIBE
SUBSCRIBE
News   Business

Abbott Laboratories Profit Jumps As All Business Units Shine

January 21, 2009 | 
1 min read
NEW YORK (Reuters) - Abbott Laboratories said on Wednesday fourth-quarter earnings jumped 28 percent on demand for its prescription drugs, nutritional products and medical devices, including its new Xience stent used to prop open coronary arteries.
Earnings
Abbott Laboratories
MORE ON THIS TOPIC
Tariffs Anxiety and tariff stress due to economic uncertainty and trade war reciprocal taxation as global imports and exports taxed causing fear and panic in the markets.
Tariffs
Most Life Sciences Companies Not Planning New Investments After Tariffs: Report
October 7, 2025
 · 
3 min read
 · 
Dan Samorodnitsky
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Pharming’s Restructuring Triggers 20% Workforce Reduction
October 7, 2025
 · 
216 min read
 · 
BioSpace Editorial Staff
Business
BioSpace Honors 40 Under 40 Winners Whose Impact Reflects Industry’s Grit
October 7, 2025
 · 
2 min read
 · 
Angela Gabriel
Facade of AstraZeneca's office in Shanghai, China
Artificial intelligence
AstraZeneca Makes Another AI Deal With $555M Algen Alliance
October 6, 2025
 · 
2 min read
 · 
Tristan Manalac